z-logo
Premium
MHC class I‐related molecule, MR 1, and mucosal‐associated invariant T cells
Author(s) -
Franciszkiewicz Katarzyna,
Salou Marion,
Legoux Francois,
Zhou Qian,
Cui Yue,
Bessoles Stéphanie,
Lantz Olivier
Publication year - 2016
Publication title -
immunological reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.839
H-Index - 223
eISSN - 1600-065X
pISSN - 0105-2896
DOI - 10.1111/imr.12423
Subject(s) - biology , effector , t cell receptor , major histocompatibility complex , antigen , intracellular , microbiology and biotechnology , phenotype , mhc class i , immunology , t cell , biochemistry , immune system , gene
Summary The MHC ‐related 1, MR 1, molecule presents a new class of microbial antigens (derivatives of the riboflavin [Vitamin B2] biosynthesis pathway) to mucosal‐associated invariant T ( MAIT ) cells. This raises many questions regarding antigens loading and intracellular trafficking of the MR 1/ligand complexes. The MR 1/ MAIT field is also important because MAIT cells are very abundant in humans and their frequency is modified in many infectious and non‐infectious diseases. Both MR 1 and the invariant TCR α chain expressed by MAIT cells are strikingly conserved among species, indicating important functions. Riboflavin is synthesized by plants and most bacteria and yeasts but not animals, and its precursor derivatives activating MAIT cells are short‐lived unless bound to MR 1. The recognition of MR 1 loaded with these compounds is therefore an exquisite manner to detect invasive bacteria. Herein, we provide an historical perspective of the field before describing the main characteristics of MR 1, its ligands, and the few available data regarding its cellular biology. We then summarize the current knowledge of MAIT cell differentiation and discuss the definition of MAIT cells in comparison to related subsets. Finally, we describe the phenotype and effector activities of MAIT cells.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here